anti-nfix Search Results


94
Bio-Techne corporation nfix antibody
Nfix Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti-nfix/NFIX+Antibody/custom%40nbp2-15039%4032291386
Average 94 stars, based on 1 article reviews
nfix antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

88
Atlas Antibodies nfix
miRNA correlation to potential targets on mRNA level of the TCGA ovarian serous cystadenocarcinoma dataset.
Nfix, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti-nfix/Anti-NFIX/pmc05998049-342-16-19
Average 88 stars, based on 1 article reviews
nfix - by Bioz Stars, 2026-11
88/100 stars
  Buy from Supplier

90
GenScript corporation anti-nfix
miRNA correlation to potential targets on mRNA level of the TCGA ovarian serous cystadenocarcinoma dataset.
Anti Nfix, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti-nfix/anti+nfix/pmc06349116-528-44-50
Average 90 stars, based on 1 article reviews
anti-nfix - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Geneka Biotechnology Inc rabbit polyclonal antibody for ngfib
miRNA correlation to potential targets on mRNA level of the TCGA ovarian serous cystadenocarcinoma dataset.
Rabbit Polyclonal Antibody For Ngfib, supplied by Geneka Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti-nfix/rabbit+anti+nfix/10__1074_slash_jbc__m405431200-125-0-10
Average 90 stars, based on 1 article reviews
rabbit polyclonal antibody for ngfib - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

N/A
The protein encoded by this gene is a transcription factor that binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3 in viral and cellular promoters. The encoded protein can also stimulate adenovirus replication in vitro. Three transcript variants encoding
  Buy from Supplier

N/A
NFIX Polyclonal Antibody
  Buy from Supplier

N/A
Boster Bio Anti-NFIX Antibody Picoband® catalog # A04138-1. Tested in ELISA, IF, ICC, WB, Flow Cytometry applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees
  Buy from Supplier


N/A
Recognizes and binds the palindromic sequence 5-TTGGCNNNNNGCCAA-3 present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication.Shipped at 4°C.
  Buy from Supplier


N/A
Recognizes and binds the palindromic sequence 5-TTGGCNNNNNGCCAA-3 present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication.Shipped at 4°C.
  Buy from Supplier

Image Search Results


miRNA correlation to potential targets on mRNA level of the TCGA ovarian serous cystadenocarcinoma dataset.

Journal: Scientific Reports

Article Title: MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells

doi: 10.1038/s41598-018-27438-6

Figure Lengend Snippet: miRNA correlation to potential targets on mRNA level of the TCGA ovarian serous cystadenocarcinoma dataset.

Article Snippet: For detection of target proteins the following antibodies were used: HNRNPC (1:1,000; #91327; Cell Signaling Technology), NFIX (1:250; HPA007533; Atlas Antibodies AB, Bromma, Sweden), Bcl2 (1:500; sc-509; Santa Cruz, Heidelberg, Germany), HNF-3α (FoxA1; 1:250; sc-514695; Santa Cruz Biotechnology), AR (1:250; sc-7305; Santa Cruz Biotechnology), Akt1/2/3 (1:500; sc-81434; Santa Cruz Biotechnology), p-Akt1/2/3 Ser473 (1:500; sc-514032; Santa Cruz Biotechnology) and GAPDH (1:5,000; MA5-15738; Thermo Fisher Scientific).

Techniques: Binding Assay

HNRNPC and NFIX as direct targets for miR-744. To validate miR-744 mediated regulation of potential target genes, SKOV3 and OVCAR3 cells were transfected with miR-744 mimic or non-targeting siRNA (NT, negative control for cell death) as described in Fig. . After 48 h, potential target gene expression was analysed by qRT-PCR. The relative mRNA expression of potential target genes was normalized to PPIA and NT employing the Livak method ( a ). Significantly downregulated potential targets were further analysed by the Luciferase Reporter Assay ( b and c ) to proof direct binding of the miRNA to its predicted target sequence. Anti-miR-744 was used to confirm the binding sides of miR-744 to the target mRNAs ( d ). The binding sites in the 3′UTR (Table ), based on data of microRNA.org and TargetScanHuman , were cloned into a pMirGLO vector. Relative luciferase activity was measured 72 h after co-transfection of the pMirGLO vector with miR-744 mimic, miRNA inhibitor anti-miR-744 or non-targeting siRNA (NT) in HEK293T cells. The relative luciferase expression was normalized to the expression after co-transfection with NT. For Western Blot analysis, SKOV3 and OVCAR3 cells were harvested 60 h after miR-744 transfection ( e ). The representative blots were stained with antibodies against NFIX and HNRNPC. GAPDH was used as loading control. Statistical differences were tested using paired t-test [n = 3 biological and technical replicates; mean ± SD; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001].

Journal: Scientific Reports

Article Title: MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells

doi: 10.1038/s41598-018-27438-6

Figure Lengend Snippet: HNRNPC and NFIX as direct targets for miR-744. To validate miR-744 mediated regulation of potential target genes, SKOV3 and OVCAR3 cells were transfected with miR-744 mimic or non-targeting siRNA (NT, negative control for cell death) as described in Fig. . After 48 h, potential target gene expression was analysed by qRT-PCR. The relative mRNA expression of potential target genes was normalized to PPIA and NT employing the Livak method ( a ). Significantly downregulated potential targets were further analysed by the Luciferase Reporter Assay ( b and c ) to proof direct binding of the miRNA to its predicted target sequence. Anti-miR-744 was used to confirm the binding sides of miR-744 to the target mRNAs ( d ). The binding sites in the 3′UTR (Table ), based on data of microRNA.org and TargetScanHuman , were cloned into a pMirGLO vector. Relative luciferase activity was measured 72 h after co-transfection of the pMirGLO vector with miR-744 mimic, miRNA inhibitor anti-miR-744 or non-targeting siRNA (NT) in HEK293T cells. The relative luciferase expression was normalized to the expression after co-transfection with NT. For Western Blot analysis, SKOV3 and OVCAR3 cells were harvested 60 h after miR-744 transfection ( e ). The representative blots were stained with antibodies against NFIX and HNRNPC. GAPDH was used as loading control. Statistical differences were tested using paired t-test [n = 3 biological and technical replicates; mean ± SD; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001].

Article Snippet: For detection of target proteins the following antibodies were used: HNRNPC (1:1,000; #91327; Cell Signaling Technology), NFIX (1:250; HPA007533; Atlas Antibodies AB, Bromma, Sweden), Bcl2 (1:500; sc-509; Santa Cruz, Heidelberg, Germany), HNF-3α (FoxA1; 1:250; sc-514695; Santa Cruz Biotechnology), AR (1:250; sc-7305; Santa Cruz Biotechnology), Akt1/2/3 (1:500; sc-81434; Santa Cruz Biotechnology), p-Akt1/2/3 Ser473 (1:500; sc-514032; Santa Cruz Biotechnology) and GAPDH (1:5,000; MA5-15738; Thermo Fisher Scientific).

Techniques: Transfection, Negative Control, Targeted Gene Expression, Quantitative RT-PCR, Expressing, Luciferase, Reporter Assay, Binding Assay, Sequencing, Clone Assay, Plasmid Preparation, Activity Assay, Cotransfection, Western Blot, Staining, Control

Predicted binding sides cloned into a pmirGlo Dual Luciferase miRNA target expression vector.

Journal: Scientific Reports

Article Title: MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells

doi: 10.1038/s41598-018-27438-6

Figure Lengend Snippet: Predicted binding sides cloned into a pmirGlo Dual Luciferase miRNA target expression vector.

Article Snippet: For detection of target proteins the following antibodies were used: HNRNPC (1:1,000; #91327; Cell Signaling Technology), NFIX (1:250; HPA007533; Atlas Antibodies AB, Bromma, Sweden), Bcl2 (1:500; sc-509; Santa Cruz, Heidelberg, Germany), HNF-3α (FoxA1; 1:250; sc-514695; Santa Cruz Biotechnology), AR (1:250; sc-7305; Santa Cruz Biotechnology), Akt1/2/3 (1:500; sc-81434; Santa Cruz Biotechnology), p-Akt1/2/3 Ser473 (1:500; sc-514032; Santa Cruz Biotechnology) and GAPDH (1:5,000; MA5-15738; Thermo Fisher Scientific).

Techniques: Binding Assay, Clone Assay, Luciferase, Expressing, Plasmid Preparation, Sequencing

Signalling pathways leading to apoptosis. Western Blot data based on literature research , after transfection of SKOV3 cells with miRNA-744 or with siRNA against NFIX ( a ) or HNRNPC ( b ) and qRT-PCR ( c ) confirmed the potential signalling pathway by reduced expression of NFIX and Bcl2 as well as diminished phosphorylation of AKT. By binding to NFIX and HNRNPC miRNA-744 is interfering with the intrinsic apoptotic pathway. Downregulation of HNRNPC resulted in enhanced expression and activation of PDCD4 and p70S6K ( e ). Reduced NFIX expression, induced by binding of miR-744, leads to reduced expression of Bcl2 leading to apoptosis ( d ). The expression analysis of miR-744 and miR-21 was normalized to the CT value of U6 snRNA . Statistical differences were tested using paired t-test. In order to analyse DNA fragmentation (cells in sub G0/G1, d ) SKOV3 cells were seeded and transfected as described in Fig. with miR-744 mimics, non-targeting siRNA (NT, negative control for cell death), or siRNA against NFIX or HNRNPC. Statistical analysis was performed by one-way ANOVA followed by Bonferroni post-test ( d ). [n = 3 technical replicates; mean ± SD; ** p < 0.01; *** p < 0.001; **** p < 0.0001]. The cells were harvested for Western Blot analysis 60 h after treatment (a and b). GAPDH was used as loading control.

Journal: Scientific Reports

Article Title: MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells

doi: 10.1038/s41598-018-27438-6

Figure Lengend Snippet: Signalling pathways leading to apoptosis. Western Blot data based on literature research , after transfection of SKOV3 cells with miRNA-744 or with siRNA against NFIX ( a ) or HNRNPC ( b ) and qRT-PCR ( c ) confirmed the potential signalling pathway by reduced expression of NFIX and Bcl2 as well as diminished phosphorylation of AKT. By binding to NFIX and HNRNPC miRNA-744 is interfering with the intrinsic apoptotic pathway. Downregulation of HNRNPC resulted in enhanced expression and activation of PDCD4 and p70S6K ( e ). Reduced NFIX expression, induced by binding of miR-744, leads to reduced expression of Bcl2 leading to apoptosis ( d ). The expression analysis of miR-744 and miR-21 was normalized to the CT value of U6 snRNA . Statistical differences were tested using paired t-test. In order to analyse DNA fragmentation (cells in sub G0/G1, d ) SKOV3 cells were seeded and transfected as described in Fig. with miR-744 mimics, non-targeting siRNA (NT, negative control for cell death), or siRNA against NFIX or HNRNPC. Statistical analysis was performed by one-way ANOVA followed by Bonferroni post-test ( d ). [n = 3 technical replicates; mean ± SD; ** p < 0.01; *** p < 0.001; **** p < 0.0001]. The cells were harvested for Western Blot analysis 60 h after treatment (a and b). GAPDH was used as loading control.

Article Snippet: For detection of target proteins the following antibodies were used: HNRNPC (1:1,000; #91327; Cell Signaling Technology), NFIX (1:250; HPA007533; Atlas Antibodies AB, Bromma, Sweden), Bcl2 (1:500; sc-509; Santa Cruz, Heidelberg, Germany), HNF-3α (FoxA1; 1:250; sc-514695; Santa Cruz Biotechnology), AR (1:250; sc-7305; Santa Cruz Biotechnology), Akt1/2/3 (1:500; sc-81434; Santa Cruz Biotechnology), p-Akt1/2/3 Ser473 (1:500; sc-514032; Santa Cruz Biotechnology) and GAPDH (1:5,000; MA5-15738; Thermo Fisher Scientific).

Techniques: Western Blot, Transfection, Quantitative RT-PCR, Expressing, Phospho-proteomics, Binding Assay, Activation Assay, Negative Control, Control